MARKET

ENLV

ENLV

Enlivex Therapeutics Ltd
NASDAQ
1.430
+0.010
+0.70%
Opening 09:59 05/21 EDT
OPEN
1.440
PREV CLOSE
1.420
HIGH
1.440
LOW
1.420
VOLUME
4.57K
TURNOVER
0
52 WEEK HIGH
4.590
52 WEEK LOW
1.150
MARKET CAP
26.90M
P/E (TTM)
-0.9138
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ENLV last week (0513-0517)?
Weekly Report · 1d ago
Weekly Report: what happened at ENLV last week (0506-0510)?
Weekly Report · 05/13 12:03
Weekly Report: what happened at ENLV last week (0429-0503)?
Weekly Report · 05/06 12:13
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Clever Leaves Holdings Inc. Shares dipped 60% to $1.6498 on Monday. The company announced it will voluntarily delist its common shares from the Nasdaq. Shares of Deciphera Pharmaceuticals, Inc. Climbed 73% in today's mid-day session.
Benzinga · 04/29 17:04
Enlivex Therapeutics: Promising Trial Results for Allocetra
TipRanks · 04/29 13:31
Weekly Report: what happened at ENLV last week (0422-0426)?
Weekly Report · 04/29 12:22
Enlivex Therapeutics Price Target Maintained With a $7.00/Share by HC Wainwright & Co.
Dow Jones · 04/23 10:43
Analysts Conflicted on These Healthcare Names: Bausch Health Companies (BHC) and Enlivex (ENLV)
TipRanks · 04/23 10:30
More
About ENLV
Enlivex Therapeutics Ltd is an Israel-based clinical stage macrophage reprogramming immunotherapy company developing Allocetra, off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state. AllocetraTM is a therapy designed to reprogram macrophages into their homeostatic state. Diseases such as solid cancers, sepsis, COVID-19 and many others reprogram macrophages out of their homeostatic state. These non-homeostatic macrophages contribute significantly to the severity of the respective diseases. By restoring macrophage homeostasis, AllocetraTM has the potential to provide immunotherapeutic mechanism of action for life-threatening clinical indications that are defined as unmet medical needs, as a stand-alone therapy or in combination with therapeutic agents.

Webull offers Enlivex Therapeutics Ltd stock information, including NASDAQ: ENLV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENLV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ENLV stock methods without spending real money on the virtual paper trading platform.